Kinobi ha scritto:Eionedvx ha scritto:Magari copia anche i due paragrafi successivi
However, the overall safety profile of Spikevax determined in adults was confirmed in the adolescent study; the CHMP therefore considered that the benefits of Spikevax in children aged 12 to 17 outweigh the risks, in particular in those with conditions that increase the risk of severe COVID-19.
The safety and efficacy of the vaccine in both children and adults will continue to be monitored closely as it is used in vaccination campaigns across the Member States, through the EU pharmacovigilance system and ongoing and additional studies by the company and by European authorities.
Il primo sottolineato: 4 su mille lo hanno contratto e non so di questi 4, "outweigh the risks, in particular in those with conditions", siano "with conditions"..
Secondo sottolineato significa: intano fallo, noi continuiamo a controllare. Intanto fallo però.
FORSE è perché quel link riporta una comunicazione ufficiale EMA e non lo studio completo...
Era piuttosto banale